Search

Your search keyword '"Connell, Carol"' showing total 460 results

Search Constraints

Start Over You searched for: Author "Connell, Carol" Remove constraint Author: "Connell, Carol"
460 results on '"Connell, Carol"'

Search Results

4. Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance.

5. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

8. Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients

9. Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study

11. Assessing the Performance of a Nutrition Knowledge Questionnaire With a Low Socioeconomic Status Population Using Rasch Analysis.

20. Mississippi Communities for Healthy Living: Results of a 6-Month Nutrition Education Comparative Effectiveness Trial

21. Evaluation of a Theory-Based Farm to School Pilot Intervention

24. Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors : a post hoc analysis of ORAL Surveillance

25. Barriers and Possible Facilitators to Participation in Farm to School Week

26. Theory of Planned Behavior and Multivitamin Supplement Use in Caucasian College Females

27. Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

28. Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

31. Enhanced Publication Content for the manuscript: Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial

32. Plain language summary for the manuscript: Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial

36. Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial

40. Examining the Diet of Post-Migrant Hispanic Males Using the Precede-Proceed Model: Predisposing, Reinforcing, and Enabling Dietary Factors

41. Energy Density, Nutrient Adequacy, and Cost per Serving Can Provide Insight into Food Choices in the Lower Mississippi Delta

42. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

43. Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial

44. Meaningful Messages: Adults in the Lower Mississippi Delta Provide Cultural Insight into Strategies for Promoting the MyPyramid

47. High Prevalence of Food Insecurity and Hunger in Households in the Rural Lower Mississippi Delta

48. Enhanced Publication Content for the manuscript: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial

49. Enhanced Publication Content for the manuscript: Risk of major adverse cardiovascular events with tofacitinib vs tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

50. Plain language summary for the manuscript: Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis

Catalog

Books, media, physical & digital resources